Reproduction/Androgen Disorders News

Testosterone replacement therapy did not improve most quality of life and psychosocial measures for men with pathological hypogonadism who were at high risk for type 2 diabetes, according to study findings.

Findings on the use of inositol for managing polycystic ovary syndrome are inconclusive, with results varying based on therapy, trial design and outcomes reported, according to a systematic review and meta-analysis.

Testosterone replacement therapy alone did not lower risk for progression from prediabetes to diabetes or increase the likelihood of type 2 diabetes remission among men with hypogonadism, according to study data.

A class of endocrine-disrupting chemical called per- and polyfluoroalkyl substances (PFAS) is no longer being used in food packaging in the U.S., according to an announcement from the FDA.

In this video exclusive, Nicole Gomez, MD, talks with Caroline T. Nguyen, MD, about diagnosing and managing thyroid dysfunction in the postpartum period.

Exposure to phthalates may have contributed to 56,595 preterm births, resulting in an additional $3.84 billion in health care costs in the U.S. during 2018, according to study data.

Exposure to phthalates may have contributed to 56,595 preterm births, resulting in an additional $3.84 billion in health care costs in the U.S. during 2018, according to study data.

In this video exclusive, Caroline T. Nguyen, MD, talks with Cynthia A. Stuenkel, MD, MSCP, about diagnosing primary ovarian insufficiency, a condition similar to but different from menopause among women younger than 40 years.

Testosterone therapy improves sexual function and quality of life for men with a baseline serum testosterone of less than 12 nmol/L, though less improvement was observed for older men and those with obesity, data show.